Phosphodiesterase-9 (PDE9) specifically hydrolyzes cyclic GMP, and was detected in human corpus cavernosum. However, no previous studies explored the selective PDE9 inhibition with BAY 73-6691 in corpus cavernosum relaxations. Therefore, this study aimed to characterize the PDE9 mRNA expression in mice corpus cavernosum, and investigate the effects of BAY 73-6691 in endothelium-dependent and -independent relaxations, along with the nitrergic corpus cavernosum relaxations. Male mice received daily gavage of BAY 73-6691 (or dimethylsulfoxide) at 3 mg kg À 1 per day for 21 days. Relaxant responses to acetylcholine (ACh), nitric oxide (NO) (as acidified sodium nitrite; NaNO 2 solution), sildenafil and electrical-field stimulation (EFS) were obtained in corpus cavernosum in control and BAY 73-6691-treated mice. BAY 73-6691 was also added in vitro 30 min before construction of concentration-responses and frequency curves. PDE9A and PDE5 mRNA expression was detected in the mice corpus cavernosum in a similar manner. In vitro addition of BAY 73-6691 neither itself relaxed mice corpus cavernosum nor changed the NaNO 2 , sildenafil and EFS-induced relaxations. However, in mice treated chronically with BAY 73-6691, the potency (pEC 50 ) values for ACh, NaNO 2 and sildenafil were significantly greater compared with control group. The maximal responses (E max ) to NaNO 2 and sildenafil were also significantly greater in BAY 73-6691-treated mice. BAY 73-6691 treatment also significantly increased the magnitude and duration of the nitrergic corpus cavernosum relaxations (8-32 Hz). In conclusion, murine corpus cavernosum expresses PDE9 mRNA. Prolonged PDE9 inhibition with BAY 73-6691 amplifies the NO-cGMP-mediated cavernosal responses, and may be of therapeutic value for erectile dysfunction.
INTRODUCTION
Phosphodiesterases (PDEs) are a large family of enzymes that specifically hydrolyze the second messengers cyclic AMP and/or cyclic GMP. There are 11 distinct PDE isoenzymes, differing in their substrate specificity, selective inhibition or stimulation by cofactors and/or standard drugs, as well as gene homology. The isoforms PDE5, PDE6 and PDE9 are specific for cGMP while PDE4, PDE7 and PDE8 are cAMP specific. The other PDEs (PDE1, PDE2, PDE3, PDE10 and PDE11) hydrolyze both cAMP and cGMP. 1, 2 PDE9 expression has been detected in various tissues, including brain, kidney, lung, heart, small intestine, prostate, bladder, hematopoietic cells and corpus cavernosum. [3] [4] [5] [6] The compound BAY 73-6691 has been described as a potent and selective cell permeable PDE9 inhibitor. 7 This inhibitor may have potential for treatment of neurodegenerative disorders such as Alzheimer's disease, improving memory via the nitric oxide (NO)/cGMP pathway in rats. 8, 9 Moreover, BAY 73-6691 reduces the neutrophil adhesion in sickle cell disease, suggesting that PDE9 inhibition in such cells may constitute an important strategy to inhibit the vaso-occlusive process in this disorder. 5 Penile erection is the final result of corpus cavernosum smooth muscle relaxation. This process is primarily initiated by NO released from nitrergic nerves and endothelial cells. 10 NO activates soluble guanylate cyclase enzyme in cavernosal smooth muscle, resulting in accumulation of intracellular cGMP and subsequent activation of cGMP-dependent protein kinase (PKG), which leads to relaxation of corpus cavernosum smooth muscle and penile erection.
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It is well established that PDE5 is the predominant isoform responsible for the metabolism of cGMP in the corpus cavernosum, ceasing the erectile responses. 12, 13 Therefore, cGMP concentration in corpus cavernosum smooth muscle is mainly dependent on the balance between the production by soluble guanylate cyclase of cGMP and the breakdown by PDEs, which represents the unique degradation pathway for this second messenger.
14 Although PDE9 is expressed in human corpus cavernosum,
MATERIALS AND METHODS Animals
The experimental protocols were approved by the Ethical Principles in Animal Research adopted by the Brazilian College for Animal Experimentation (COBEA). Male C57BL/6 mice (30 g) were provided by Central animal House Services (CEMIB) of University of Campinas (UNICAMP, São Paulo). The animals were housed five per cage on 12 h light-dark cycle, and fed a standard chow diet with water ad libitum.
Functional studies in cavernosal strips
The penis was removed and immediately placed in chilled Krebs solution of the following composition: NaCl, 118 mM; NaHCO 3 , 25 mM; glucose, 5.6 mM; KCl, 4.7 mM; KH 2 PO 4 , 1.2 mM; MgSO 4 7 H 2 O, 1.17 mM and CaCl 2 2H 2 O, 2.5 mM. After removal of the vein and urethra, the penile tissue was cleaned from the connective and adventitial tissue, and the fibrous septum separating the corpora cavernosa was opened from its proximal extremity toward the penile shaft. A slit was made in the tunica albuginea along the shaft to obtain two strips (B10 Â 1 Â 1 mm) of corpus cavernosum from each animal. Each strip was mounted under resting tension of 2.5 mN in 10-ml organ chambers containing Krebs solution at 37 1C (pH 7.4) and continuously bubbled with a mixture of 95% O 2 and 5% CO 2 .
15 Isometric force was recorded using a PowerLab 400 data acquisition system (Software Chart, version 7.0; AD Instrument, Milford, MA, USA). The tissues were allowed to equilibrate for 1 h before starting the experiments. Cumulative concentration-response curves to ACh (1 nM to 3 mM, endothelium-dependent vasodilator), NO (added as acidified sodium nitrite (NaNO 2 ) solution; 1 nM-100 mM) or sildenafil (1 nM-10 mM) were obtained in cavernosal strips contracted with phenylephrine (PE; 10 mM, a1-adrenergic receptor agonist). Non-linear regression analysis to determine the potency (pEC 50 ) was carried out using GraphPad Prism (GraphPad Software, San Diego, CA, USA).
Electrical-field stimulation EFS was applied in cavernosal strips placed between two platinum ring electrodes connected to a grass S88 stimulator (Astro-Med Industrial Park, West Warwick, RI, USA). EFS was conducted at 50 V, 1-ms pulse width and trains of stimuli lasting 10 s at varying frequencies (1-32 Hz). To study the nitrergic relaxations, cavernosal tissues were pretreated with guanethidine (30 mM) and atropine (1 mM) to deplete the catecholamine stores and to block the cholinergic receptors, respectively.
Experimental groups
Animals were divided into control group (mice received tap water alone together with 100% dimethylsulfoxide (DMSO) (200 ml) as daily gavage for 21 days) and BAY 73-6691 group (mice received BAY 73-6691 at 3 mg kg À 1 per day as daily oral gavage for 21 days). This dose of BAY 73-6691 was chosen according to a previous study. 8 Concentration-response curves to ACh, NaNO 2 and sildenafil, along with the nitrergic relaxations, were obtained in corpus cavernosum, as detailed above. In separate experiments, BAY 73-6691 was added in vitro (1 mM) to the organ bath 30 min before construction of concentration-responses and frequency curves.
Reverse transcription of mRNA and amplification and quantification of PDE type-5 and -9A gene expression by real-time PCR Total RNA was extracted with Trizol Reagent (Invitrogen Corp., Carlsbad, CA, USA) from corpus cavernosum mice samples. Three microgram RNA samples were incubated with 1 U DNaseI (Invitrogen, Rockville, MD, USA) for 15 min at room temperature and EDTA was added to a final concentration of 2 mM to stop the reaction. The DNaseI enzyme was subsequently inactivated by incubation at 65 1C for 5 min. DNaseI-treated RNA samples were then reverse transcribed with Superscript III and RNaseOut (Invitrogen Corp., Carlsbad, CA, USA) for 50 min at 50 1C, 15 min at 70 1C. cDNA samples were quantified using a Nanodrop spectrophotometer (ND-1000; Nanodrop Technologies Inc., Wilmington, DE, USA). Synthetic oligonucleotide primers were designed to amplify cDNA for PDE type-5 and -9A (PDE5 and PDE9A, respectively; PrimerExpress; Applied Biosystems, Foster City, CA, USA). Primer sequences for PDE5 were the following: 5 0 -GGAAATGGTGGGACCTTCACT-3 0 and reverse 5 0 -AAGAACAA-TACCACAGAATGCCA-3 0 , primer sequences for PDE9A were the following: 5 0 -TTTAACCACAGACGACGCCA-3 0 and reverse 5 0 -GTAGGGAGTGCGCTCTGA ATT-3 0 . All samples were assayed in a 25-ml volume containing 10 ng cDNA, 12.5 ml SYBR Green Master Mix PCR (Applied Biosystems) and 300 nM of primers in a MicroAmp Optical 96-well reaction plate (Applied Biosystems) using the 7200 Sequence Detection System (Applied Biosystems). To confirm accuracy and reproducibility of real-time PCR, the intra-assay precision was calculated according to the equation: E ¼ 10
, where the PCR efficiency was calculated. The transcripts assayed demonstrated high real-time PCR efficiency rates of over 99% for primer utilized (Pearson correlation coefficient r40.95). Threshold cycle (Ct) was defined as the point at which the fluorescence rises appreciably above the background fluorescence. The dissociation protocol was performed at the end of each run to check for non-specific amplification. All samples were amplified in duplicate, and the mean of the threshold cycle was used for further calculations. The probe signal was normalized to an internal reference, and GAPDH was used as reference gene and fold increase was calculated by the conventional DDCt method.
Drugs and chemicals
ACh, atropine, guanethidine, PE, NaNO 2 , DMSO and BAY 73-6691 were purchased from Sigma-Aldrich (St Louis, MO, USA). Sildenafil citrate was obtained from Pfizer, Inc. (New York, NY, USA). All reagents used were of analytical grade. Stock solutions were prepared in deionized water or DMSO and stored in aliquots at À 20 1C; dilutions were prepared immediately before use. The responses to NO were obtained by adding NaNO 2 solution adjusted to pH 2.0, and concentrations of the solution in the bathing medium were expressed as those of NO. [16] [17] Statistical analysis Data are expressed as means ± s.e.m. of n experiments. The program Instat (GraphPad software) was used for statistical analysis. Analysis of variance was performed, and Tukey method was chosen as a post-test. Student's t-test was performed when appropriate. Po0.05 was considered statistically significant.
RESULTS
Expression of mRNA of PDE9A and PDE5 in mice corpus cavernosum PDE9A and PDE5 mRNA expression was detected in the corpus cavernosum of mice. Both isoforms were expressed at similar levels ( Figure 1 ).
Concentration-dependent relaxations to ACh, NaNO 2 and sildenafil in BAY 73-6691-treated mice Mice received BAY 73-6691 at 3 mg kg À 1 per day as daily oral gavage for 21 days (or vehicle), after which concentrationresponse relaxing curves to ACh, NaNO 2 and sildenafil were obtained in corpus cavernosum. PE (10 mM) caused a submaximal contraction in mice corpus cavernosum preparations and generated active force of 0.26 ± 0.05 mN (n ¼ 25) from control group and 0.31 ± 0.04 mN (n ¼ 21) from control BAY 73-6691 chronic group (70-80% of the maximal response). There were no significant differences in the levels of contraction at the chosen PE concentration. In PE-precontracted cavernosal strips, cumulative addition of ACh (1 nM-3 mM), NaNO 2 (1 nM-100 mM) or sildenafil (1 nM-10 mM) produced concentration-dependent relaxations (Figures 2a-c) . The potency (pEC 50 ) values for ACh, NaNO 2 and sildenafil were 2.2-, 4.7-and 5.3-fold greater (Po0.05) in cavernosal strips taken from BAY 73-6691-treated mice, respectively, compared with control group (Table 1) . The maximal responses (E max ) to NaNO 2 and sildenafil were also significantly greater in BAY 73-6691-treated mice (Po0.05) whereas E max to ACh remained unchanged (Table 1 ). In BAY 73-6691-treated mice, sildenafil produced corpus cavernosum relaxations below the calibrated baseline ( Figure 2c) ; therefore, in this case in particular, we recognize that caution should be taken when interpreting the pEC 50 values (Table 1) .
Nitrergic relaxations in BAY 73-6691-treated mice EFS (1-32 Hz) produced frequency-dependent corpus cavernosum relaxations in both control and BAY 73-6691 groups (Figure 3a) . Treatment with BAY 73-6691 significantly increased the relaxations of corpus cavernosum at frequencies of 8-32 Hz in comparison with control group. The duration of nitrergic relaxations was also significantly increased by BAY 73-6691 treatment (Figure 3b ).
Corpus cavernosum relaxations to BAY 73-6691 in vitro Addition of BAY 73-6691 (1 mM) to PE-contracted tissues did not produce mice corpus cavernosum relaxations compared with vehicle DMSO (0.2%) (E max : 20 ± 3% and 22 ± 2% relaxation for BAY 73-6691 and vehicle, respectively; n ¼ 5). In vitro addition of BAY 73-6691 (1 mM, 30 min) also failed to significantly affect the NaNO 2 and sildenafil-induced relaxations at the level of pEC 50 and E max ( Table 1 ). The nitrergic relaxations were also unaffected by BAY 73-6691 in vitro (8 Hz: 49±4.6% and 56±6%; 16 Hz: 50±4% and 55±5% for control and BAY 73-6691, respectively; n ¼ 5).
DISCUSSION
Our present findings show that PDE9A mRNA is abundantly expressed in the mice corpus cavernosum and that the prolonged PDE9 inhibition with BAY 73-6691 improves endothelium-dependent and -independent as well as nitrergic cavernosal relaxations in vitro.
The PDE9 isoform specifically hydrolyze the second messenger cGMP 2, 18 and therefore may constitute an important pharmacological target for the treatment of erectile dysfunction. Our data showed that PDE9A and PDE5 mRNA are expressed at similar levels in mice corpus cavernosum. Stimulation of non-noradrenergic, per day for 21 days). Data were calculated relative to the maximal changes from the contraction produced by phenylephrine (PE) (10 mM) in each tissue, which was taken as 100%. Data represent the means ± s.e.m. for 5-12 mice in each group. * Po0.05 compared with the respectively control. Abbreviations: DMSO, dimethylsulfoxide; NaNO 2 , sodium nitrite; ND, not determined. BAY 73-6691 (10 mM) was added in vitro to the organ bath before construction of concentration-response curves. A separate group of mice received daily oral gavage of BAY 73-6691 (3 mg kg À 1 per day for 21 days) or its vehicle (DMSO), after which concentration-response curves ACh, NaNO 2 and sildenafil were obtained. pEC 50 is represented as À log of the molar concentration to produce 50% of the maximal contractile response elicited by ACh, NaNO 2 and sildenafil. Data represent mean ± s.e.m. *** non-cholinergic neurons (NANC) nitrergic neurons and endothelial cells in the erectile tissue results in release of NO that diffuses to surrounding smooth muscle cells where it activates soluble guanylate cyclase, facilitating the conversion of GTP to cGMP. 13 We next investigated the relaxing effect of the PDE9 inhibitor BAY 73-6691 in mice corpus cavernosum in vitro. Addition of BAY 73-6691 to the organ bath neither produced corpus cavernosum relaxations itself nor significantly potentiated the relaxations induced by NaNO 2 , sildenafil and EFS. However, 21 days treatment with BAY 73-6691 markedly increased the magnitude and duration of the nitrergic relaxations. BAY 73-6691 also caused marked leftward shifts in the concentration-response curves to ACh, NaNO 2 and sildenafil in the mice corpus cavernosum, suggesting that prolonged PDE9 inhibition acts to amplify the cGMP-mediated cell responses. The reasons why prolonged treatment with BAY 73-6691 (but not in vitro addition) improves corpus cavernosum relaxations remains to be elucidated. To our knowledge, this is the first study demonstrating that PDE9 chronic inhibition exerts significant effects on relaxing mice CC and requires further study to understand the pharmacodynamics and pharmacokinetics aspects of this drug orally administered.
The PDE5 inhibitors generally increase and prolong the neurogenic NO-mediated cavernosal and ACh-induced relaxations in animal and human corpus cavernosum, either as oral pretreatment or by in vitro addition. [19] [20] [21] [22] [23] [24] [25] BAY 73-6691 selectively inhibits human and murine PDE9 activity in vitro (IC 50 ¼ 55 and 100 nM, respectively) and shows only discrete activity against PDE5 (IC 50 44000 nM) in an ovary cell line. 7 Therefore, it is unlikely that enhancement of corpus cavernosum relaxations by BAY 73-6691 reflects a unespecific inhibitory effect at the PDE5 isoform. In hamster ovary cell line, BAY 73-6691 alone failed to significantly increase the basal cGMP levels; however, BAY 73-6691, in combination with the soluble guanylate cyclase activator (BAY 58-2667), concentration dependently enhanced the intracellular cGMP accumulation in this cell line. 7 Of interest, under biochemical conditions in which PDE9 is fully active, cGMP was cleaved in a few seconds, and an enzyme/product (PDE9/5 0 -GMP) complex was captured as secondary to the hydrolysis reaction. 18 This is consistent with the conclusions that cGMP hydrolysis is fast and that 5 0 -GMP dissociation is the rate-limiting step of the reaction. 18 In conclusion, murine corpus cavernosum expresses PDE9 mRNA, and prolonged blockade of PDE9 activity with BAY 73-6691 amplifies the NO-cGMP-mediated cavernosal responses. Therefore, long-term treatment with BAY 73-6691 could be beneficial for erectile dysfunction. 
